Nuwellis Shares Outstanding 2011-2023 | NUWE
Nuwellis shares outstanding from 2011 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Nuwellis Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 2 |
| 2022 | 0 |
| 2021 | 0 |
| 2020 | 0 |
| 2019 | 0 |
| 2018 | 0 |
| 2017 | 0 |
| 2016 | 0 |
| 2015 | 1 |
| 2014 | 17 |
| 2013 | 13 |
| 2012 | 7 |
| 2011 | 5 |
| 2010 | 3 |
| Nuwellis Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 2 |
| 2023-09-30 | 2 |
| 2023-06-30 | 1 |
| 2023-03-31 | 1 |
| 2022-12-31 | 0 |
| 2022-09-30 | 0 |
| 2022-06-30 | 0 |
| 2022-03-31 | 0 |
| 2021-12-31 | 0 |
| 2021-09-30 | 0 |
| 2021-06-30 | 0 |
| 2021-03-31 | 0 |
| 2020-12-31 | 0 |
| 2020-09-30 | 0 |
| 2020-06-30 | 0 |
| 2020-03-31 | 0 |
| 2019-12-31 | 0 |
| 2019-09-30 | 0 |
| 2019-06-30 | 0 |
| 2019-03-31 | 0 |
| 2018-12-31 | 0 |
| 2018-09-30 | 0 |
| 2018-06-30 | 0 |
| 2018-03-31 | 0 |
| 2017-12-31 | 0 |
| 2017-09-30 | 0 |
| 2017-06-30 | 0 |
| 2017-03-31 | 0 |
| 2016-12-31 | 0 |
| 2016-09-30 | 0 |
| 2016-06-30 | 1 |
| 2016-03-31 | 1 |
| 2015-12-31 | 1 |
| 2015-09-30 | 18 |
| 2015-06-30 | 18 |
| 2015-03-31 | 18 |
| 2014-12-31 | 17 |
| 2014-09-30 | 17 |
| 2014-06-30 | 17 |
| 2014-03-31 | 17 |
| 2013-12-31 | 13 |
| 2013-09-30 | 13 |
| 2013-06-30 | 12 |
| 2013-03-31 | 9 |
| 2012-12-31 | 7 |
| 2012-09-30 | 8 |
| 2012-06-30 | 6 |
| 2012-03-31 | 6 |
| 2011-12-31 | 5 |
| 2011-09-30 | 6 |
| 2011-06-30 | 5 |
| 2011-03-31 | 5 |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.002B | $0.009B |
| Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for ultrafiltration therapy. Nuwellis Inc., formerly known as CHF Solutions, is headquartered in Minneapolis, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| Edwards Lifesciences (EW) | United States | $52.819B | 34.96 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Masimo (MASI) | United States | $7.246B | 40.64 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |